RecruitingNot applicableNCT04073797

PET Imaging of Inflammation and Lipid Lowering Study

Studying Genetic vascular anomaly

Last synced from ClinicalTrials.gov May 9, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Cambridge
Principal Investigator: Jason M Tarkin, MBBS PhD
University of Cambridge
Intervention: Inclisiran(drug)
Enrollment: 63 target
Eligibility: 18-99 years · All sexes
Timeline: 2023 – 2026

Study locations (1)

University of Cambridge, Cambridge, United Kingdom

Collaborators

Cambridge University Hospitals NHS Foundation Trust · Wellcome Trust · GE Healthcare · Lund University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04073797 on ClinicalTrials.gov

Other trials for Genetic vascular anomaly

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00178594
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
The University of Texas Health Science Center, Houston

See all trials for Genetic vascular anomaly →

← Back to all trials